PhoenixBio Co.,Ltd.
| Market Cap | 1.9B |
| P/E Ratio | - |
| P/B Ratio | 1.22 |
| EPS | -110.99 |
| Dividend Yield | - |
| D/E Ratio | 0.67 |
| Current Ratio | 3.03 |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
Business Overview
PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | IT & SERVICES, OTHERS |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | PhoenixBio Co.,Ltd. |
| Ticker | 6190 |
| Exchange | TSE |
| Sector | Services |
| Industry | IT & SERVICES, OTHERS |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Fiscal Year | 2025 |
| Currency | JPY |
| Market Cap | 1.9B |
| Revenue | 1.5B |
| Net Income | -448.9M |
| P/E Ratio | - |
| EPS | -110.99 |
| Net Margin | -29.1% |
| ROE | -32.9% |
| Dividend Yield | - |
PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.